These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21726771)

  • 1. A new salicylic acid-derivatized kojic acid vanadyl complex: synthesis, characterization and anti-diabetic therapeutic potential.
    Wei Y; Zhang C; Zhao P; Yang X; Wang K
    J Inorg Biochem; 2011 Aug; 105(8):1081-5. PubMed ID: 21726771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization and anti-diabetic therapeutic potential of a new benzyl acid-derivatized kojic acid vanadyl complex.
    Wei YB; Yang XD
    Biometals; 2012 Dec; 25(6):1261-8. PubMed ID: 23015214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
    J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.
    Thompson KH; Chiles J; Yuen VG; Tse J; McNeill JH; Orvig C
    J Inorg Biochem; 2004 May; 98(5):683-90. PubMed ID: 15134913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of BMOV [bis(maltolato)oxovanadium(IV)] on biochemical and morphological alterations characteristic for streptozotocin-diabetic rat liver Golgi complexes.
    Dabroś W; Dziga D; Kordowiak AM
    Pol J Pathol; 2002; 53(4):205-13. PubMed ID: 12597338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats.
    Kordowiak AM; Dabroś W; Kajda B
    Horm Metab Res; 2002 Oct; 34(10):556-60. PubMed ID: 12439783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new orally active antidiabetic vanadyl complex--bis(alpha-furancarboxylato)oxovanadium(IV).
    Xie M; Gao L; Li L; Liu W; Yan S
    J Inorg Biochem; 2005 Feb; 99(2):546-51. PubMed ID: 15621288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptozotocin-induced alterations in rat liver Golgi complexes are ameliorated by BMOV [Bis(maltolato)oxovanadium(IV)] activity.
    Kordowiak AM; Dziga D; Dabroś W
    Horm Metab Res; 2004 Mar; 36(3):148-54. PubMed ID: 15057667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the hypoglycemic action of vanadium compounds related to the suppression of feeding?
    Huang M; Wu Y; Wang N; Wang Z; Zhao P; Yang X
    Biol Trace Elem Res; 2014 Mar; 157(3):242-8. PubMed ID: 24446192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent-diabetes.
    Shinde UA; Mehta AA; Goyal RK
    Indian J Exp Biol; 2001 Sep; 39(9):864-70. PubMed ID: 11831366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
    Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
    J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
    Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
    Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-diabetic effects and pharmacokinetic profiles of bis(maltolato)oxovanadium in non-diabetic and diabetic rats.
    Zhang SQ; Zhong XY; Chen GH; Lu WL; Zhang Q
    J Pharm Pharmacol; 2008 Jan; 60(1):99-105. PubMed ID: 18088510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemic effect of macrocyclic binuclear oxovanadium (IV) complex on streptozotocin-induced diabetic rats.
    Ramachandran B; Sekar DS; Kandaswamy M; Narayanan V; Subramanian S
    Exp Diabesity Res; 2004; 5(2):137-42. PubMed ID: 15203884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, spectroscopic, structural and thermal characterizations of vanadyl(IV) adenine complex prospective as antidiabetic drug agent.
    El-Megharbel SM; Hamza RZ; Refat MS
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():850-64. PubMed ID: 25150436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
    Yao J; Battell ML; McNeill JH
    Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
    Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
    J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-diabetic activity of new N,N-dimethylphenylenediamine-derivatized nitrilotriacetic acid vanadyl complexes.
    Niu X; Yang J; Yang X
    J Inorg Biochem; 2017 Dec; 177():291-299. PubMed ID: 28709620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
    Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
    Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.